Pfizer-BioNTech vaccine effective against mutation in new coronavirus strains, study finds

Pfizer and BioNTech’s Covid-19 vaccine appeared to work against a key mutation in the highly transmissible new variants of the coronavirus discovered in Britain and South Africa, according to a laboratory study conducted by the US drug maker.The study by Pfizer and scientists from the University of Texas Medical Branch, which has not yet been peer-reviewed, indicated the vaccine was effective in neutralising virus with the so-called N501Y mutation of the spike protein.The mutation could be…

Read the original article at South China Morning Post